These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3906186)

  • 1. [Comparison of i-PiT, TDX and EMIT measurement of serum phenytoin and digoxin levels].
    Koizumi F; Kumai M; Ishimori A
    Rinsho Byori; 1985 Jul; 33(7):761-70. PubMed ID: 3906186
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of total and free phenytoin in serum by non-isotopic immunoassays and gas chromatography.
    Külpmann WR; Gey S; Beneking M; Kohl B; Oellerich M
    J Clin Chem Clin Biochem; 1984 Nov; 22(11):773-9. PubMed ID: 6396367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nephelometric inhibition immunoassay (NIIA), a new methodology for the determination of phenobarbital and phenytoin concentration in serum (author's transl)].
    Liappis N
    Klin Padiatr; 1982 Mar; 194(2):88-90. PubMed ID: 7047885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of the Abbott TDx fluorescence polarization immunoassay analyzer.
    Oeltgen PR; Shank WA; Blouin RA; Clark T
    Ther Drug Monit; 1984; 6(3):360-7. PubMed ID: 6390799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Ames Seralyzer for the therapeutic drug monitoring of phenobarbital and phenytoin.
    Brettfeld C; Gobrogge R; Massoud N; Munzenberger P; Nigro M; Sarnaik A
    Ther Drug Monit; 1989 Sep; 11(5):612-5. PubMed ID: 2683255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of albumin on digoxin determination by the TDX system].
    Koizumi F; Sato T; Honda I; Ishimori A
    Rinsho Byori; 1987 Apr; 35(4):463-4. PubMed ID: 3302408
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenytoin and phenobarbital concentrations in serum: a comparison of Ames Seralyzer with GLC, TDX, and EMIT.
    Leppik IE; Oles KS; Sheehan ML; Penry JK; Parker DR; Gallagher TK; Caron GP; Rosenfeld W; Salmon JJ
    Ther Drug Monit; 1989; 11(1):73-8. PubMed ID: 2643204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of C-reactive protein in serum using a fluorescence polarization immunoassay--comparison with the method of kinetic nephelometry (KNM)].
    Liappis N; Jäkel A
    Klin Padiatr; 1987; 199(1):45-7. PubMed ID: 3560764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical specificity of commercially available methods for serum phenytoin determination.
    Haughey DB; Matzke GR; Halstenson CE; Keane WF
    J Anal Toxicol; 1984; 8(3):106-11. PubMed ID: 6376948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of digoxin concentrations in serum by fluorescence polarization immunoassay: an evaluation.
    Ferreri LF; Raisys VA; Opheim KE
    J Anal Toxicol; 1984; 8(3):138-40. PubMed ID: 6376949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of human, bovine, and newborn calf serum in the preparation of external quality assurance samples for therapeutic drugs.
    Tsanaclis LM; Wilson JF; Williams J; Perrett JE; Richens A
    Ther Drug Monit; 1990 Jul; 12(4):373-7. PubMed ID: 2204152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum creatinine concentration and the discrepancy between enzyme multiplied immunoassay technique and gas-liquid chromatographic phenytoin levels.
    Apple FS; Walker FC; Dietzler DN
    Ann Clin Lab Sci; 1983; 13(5):385-92. PubMed ID: 6357047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an immunoturbidimetric assay of serum digoxin without sample pretreatment.
    Ruiz R; Borque L; Soria AG; Córdova MA; Asolo B
    Eur J Clin Chem Clin Biochem; 1995 Mar; 33(3):171-5. PubMed ID: 7605830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring in patients with chronic renal failure: evaluation of the Abbott TDx drug assay system.
    Sedman AJ; Molitoris BA; Nakata LM; Gal J
    Am J Nephrol; 1986; 6(2):132-4. PubMed ID: 3085501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of digoxin concentrations determined by three assay systems: TDx, IMx and OPUS.
    Kagawa Y; Iwamoto T; Matsuda H; Mukohara R; Sawada J; Kojima M
    Biopharm Drug Dispos; 2004 Jan; 25(1):21-6. PubMed ID: 14716749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraprotein interference in immunoassays.
    LeGatt DF; Higgins TN
    Ther Drug Monit; 2015 Jun; 37(3):417. PubMed ID: 25478903
    [No Abstract]   [Full Text] [Related]  

  • 17. Interference in immunoassay measurements of total and free phenytoin in uremic patients: a reappraisal.
    Roberts WL; Rainey PM
    Clin Chem; 1993 Sep; 39(9):1872-7. PubMed ID: 8375063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of serum phenytoin determination by the substrate-labeled fluorescent immunoassay with gas chromatography, liquid chromatography, radioimmunoassay and "EMIT".
    Wong RC; George R; Yeung R; Burd JF
    Clin Chim Acta; 1980 Jan; 100(1):65-9. PubMed ID: 6985851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate-labeled fluorescent immunoassay for phenytoin in human serum.
    Wong RC; Burd JF; Carrico RJ; Buckler RT; Thoma J; Boguslaski RC
    Clin Chem; 1979 May; 25(5):686-91. PubMed ID: 108033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luminescence immunoassays of proteins with reference to the quantitation of a human placental function protein HPL.
    Tiffany TO; Hallworth MJ; Price CP
    Ric Clin Lab; 1982; 12(1):255-63. PubMed ID: 7046019
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.